C. Spadone

538 total citations
21 papers, 269 citations indexed

About

C. Spadone is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, C. Spadone has authored 21 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Psychiatry and Mental health and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in C. Spadone's work include Treatment of Major Depression (9 papers), Schizophrenia research and treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). C. Spadone is often cited by papers focused on Treatment of Major Depression (9 papers), Schizophrenia research and treatment (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). C. Spadone collaborates with scholars based in France, Austria and Switzerland. C. Spadone's co-authors include Patrice Verpillat, Siegfried Kasper, Jules Angst, J P Olié, J.P. Lépine, Pierre‐Michel Llorca, Emmanuelle Corruble, Thierry Bougerol, Olivier Sol and Dominique Servant and has published in prestigious journals such as The Journal of Clinical Psychiatry, Biomedicine & Pharmacotherapy and International Clinical Psychopharmacology.

In The Last Decade

C. Spadone

19 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Spadone France 7 108 92 91 63 43 21 269
A A Nierenberg United States 10 159 1.5× 180 2.0× 95 1.0× 97 1.5× 39 0.9× 17 379
J. J. López-Ibor Spain 8 138 1.3× 122 1.3× 49 0.5× 46 0.7× 46 1.1× 21 312
J. Andersen Denmark 10 119 1.1× 204 2.2× 84 0.9× 82 1.3× 44 1.0× 16 370
Alessia Gatti Italy 4 147 1.4× 116 1.3× 84 0.9× 53 0.8× 23 0.5× 5 285
S Yasmin United States 7 191 1.8× 179 1.9× 92 1.0× 40 0.6× 40 0.9× 12 314
Signe Hellmuth Denmark 4 107 1.0× 70 0.8× 55 0.6× 50 0.8× 22 0.5× 6 316
A Khan United States 10 171 1.6× 141 1.5× 131 1.4× 49 0.8× 49 1.1× 23 481
K. Hewett United Kingdom 7 158 1.5× 101 1.1× 130 1.4× 70 1.1× 48 1.1× 11 324
Maria Iversen Denmark 3 126 1.2× 86 0.9× 57 0.6× 52 0.8× 17 0.4× 4 280
Stephen T.H. Sokolov Canada 11 172 1.6× 149 1.6× 56 0.6× 53 0.8× 58 1.3× 13 370

Countries citing papers authored by C. Spadone

Since Specialization
Citations

This map shows the geographic impact of C. Spadone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Spadone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Spadone more than expected).

Fields of papers citing papers by C. Spadone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Spadone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Spadone. The network helps show where C. Spadone may publish in the future.

Co-authorship network of co-authors of C. Spadone

This figure shows the co-authorship network connecting the top 25 collaborators of C. Spadone. A scholar is included among the top collaborators of C. Spadone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Spadone. C. Spadone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spadone, C.. (2011). 8e Workshop international sur la neuroplasticité, 23–24 octobre 2010. L Encéphale. 37(3). 238–240. 1 indexed citations
2.
Spadone, C. & Emmanuelle Corruble. (2010). Symptômes résiduels et récidive dans le trouble dépressif majeur. L Encéphale. 36. S108–S111. 1 indexed citations
3.
Spadone, C.. (2010). Psychiatrie de liaison : quelle psychiatrie pour quelles liaisons ?. Annales Médico-psychologiques revue psychiatrique. 168(3). 205–209. 1 indexed citations
4.
Spadone, C.. (2009). Formes sévères de dépression : efficacité de l’escitalopram. L Encéphale. 35(2). 152–159. 2 indexed citations
5.
Spadone, C.. (2009). Efficacité de l’escitalopram et sévérité de la dépression : nouvelles données. L Encéphale. 35(6). 577–585. 1 indexed citations
6.
Spadone, C.. (2008). Rémission cognitive et rémission clinique de la dépression. L Encéphale. 34(2). 211–213. 1 indexed citations
7.
Spadone, C., et al.. (2008). L’étifoxine : un nouveau regard sur le récepteur GABA et l’anxiété. L Encéphale. 34(1). 1–11. 1 indexed citations
8.
Gaillard, Raphaël, et al.. (2006). Benzodiazépines et schizophrénie, revue de la littérature. L Encéphale. 32(6). 1003–1010. 8 indexed citations
9.
Kasper, Siegfried, C. Spadone, Patrice Verpillat, & Jules Angst. (2006). Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. International Clinical Psychopharmacology. 21(2). 105–110. 69 indexed citations
10.
Spadone, C.. (2006). Puede curarse la depresión. Dialnet (Universidad de la Rioja). 1 indexed citations
11.
12.
Spadone, C.. (2003). [Effects of escitalopram on anxiety symptoms in depression].. PubMed. 28(5 Pt 1). 461–5. 8 indexed citations
13.
Olié, J P, et al.. (2003). [Antidepressants consumption in the global population in France].. PubMed. 28(5 Pt 1). 411–7. 44 indexed citations
14.
Llorca, Pierre‐Michel, C. Spadone, Olivier Sol, et al.. (2002). Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 63(11). 1020–1027. 84 indexed citations
15.
Gourion, David & C. Spadone. (2002). Utilisation des antipsychotiques à doses élevées. L Évolution Psychiatrique. 67(1). 184–198. 1 indexed citations
16.
Laqueille, Xavier, et al.. (1996). Treatment of depressive syndromes in detoxified drug addicts: use of methadone. Biomedicine & Pharmacotherapy. 50(6-7). 279–282. 6 indexed citations
17.
Sarfati, Yves, C. Spadone, Jean‐Marie Vanelle, & H. Lôo. (1996). [Calcium antagonists and lithium in preventive treatment of manic-depressive disorder].. PubMed. 22(2). 149–53. 3 indexed citations
18.
Gallarda, Thierry, et al.. (1996). [A case of "dementia praecox" in a 23 year old woman: Pick's juvenile dementia or hebephrenic-catatonic schizophrenia?].. PubMed. 154(3). 186–90. 1 indexed citations
19.
Tabbane, Karim, et al.. (1994). [Mortality and cause of death in schizophrenia. Review of the literature].. PubMed. 19(1). 23–8. 21 indexed citations
20.
Spadone, C.. (1993). [Neurophysiology of cannabis].. PubMed. 17(1). 17–22. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A A Nierenberg Breakdown of academic impact, for papers by J. J. López-Ibor Breakdown of academic impact, for papers by J. Andersen Breakdown of academic impact, for papers by Alessia Gatti Breakdown of academic impact, for papers by S Yasmin Breakdown of academic impact, for papers by Signe Hellmuth Breakdown of academic impact, for papers by A Khan Breakdown of academic impact, for papers by K. Hewett Breakdown of academic impact, for papers by Maria Iversen Breakdown of academic impact, for papers by Stephen T.H. Sokolov
Rankless by CCL
2026